Advertisement

Topics

CytoDyn raises over $12M as it looks to commercialize lead drug leronlimab

04:05 EDT 14 Jun 2019 | Proactive Investors

CEO Nader Pourhassan says the ‘level of investor participation” in the recent capital raises give 'credence' to the company’s mission

Original Article: CytoDyn raises over $12M as it looks to commercialize lead drug leronlimab

NEXT ARTICLE

More From BioPortfolio on "CytoDyn raises over $12M as it looks to commercialize lead drug leronlimab"

Advertisement
Quick Search
Advertisement
Advertisement